Related Experiment Videos
Splenectomy for haematological diseases--a single institution experience
M Mittelman1, S Kyzer, A Zeidman
1Department of Medicine B, Petah-Tikva, Sackler Medical School, Tel-Aviv University, Israel.
Haematologia
|January 1, 1997
Summary
Splenectomy is a safe and effective treatment for various hematological diseases, offering significant improvements in conditions like immune thrombocytopenic purpura and anemia. This retrospective analysis highlights its therapeutic and diagnostic benefits.
Area of Science:
- Hematology
- Surgical Oncology
- Internal Medicine
Background:
- Splenectomy is a surgical procedure to remove the spleen.
- It is indicated for various hematological conditions, including immune thrombocytopenic purpura (ITP), lymphoproliferative (LP) disorders, and immune hemolytic anemia (IHA).
- Evaluating the outcomes of splenectomy in hematological diseases is crucial for understanding its efficacy and safety.
Purpose of the Study:
- To assess the 15-year experience with splenectomy for hematological diseases.
- To identify the specific diseases and indications necessitating splenectomy.
- To analyze the perioperative complications and hematological results following splenectomy.
Main Methods:
- A retrospective analysis was conducted at a single institution.
- Data from 69 patients who underwent splenectomy for hematological diseases between 1980 and 1994 were reviewed.
- Parameters studied included patient characteristics, hematological disorders, splenic size, complications, and surgical outcomes.
Main Results:
- Immune thrombocytopenic purpura (ITP) was the most common indication for splenectomy (26%), followed by lymphoproliferative (LP) disorders (17.4%) and immune hemolytic anemia (IHA) (13%).
- Splenectomy was performed for therapeutic (75.4%) and diagnostic (36.2%) purposes.
- No perioperative mortality occurred; 30.4% of patients experienced complications, primarily bleeding (13%) and infection (14.5%).
- Complete response was observed in 76.5% of patients for platelet count, 64.7% for hemoglobin, and 88.9% for white blood cell count.
Conclusions:
- Splenectomy is a relatively safe and effective procedure for both therapeutic and diagnostic management of hematological diseases.
- The study demonstrates significant hematological improvements post-splenectomy, particularly in ITP, IHA, and cytopenic conditions.
- Long-term follow-up data are needed to fully assess the prognosis for conditions like myeloproliferative and lymphoproliferative disorders.